News Quantified

TTRX – turn therapeutics inc. (US:NASDAQ)

Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference

1/7

04:05 pm

ttrx

Low

Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors

Turn Therapeutics (NASDAQ:TTRX) is now covered by analysts at Weiss Ratings. They set a "sell (e-)" rating on the stock.

Turn Therapeutics (NASDAQ:TTRX) was upgraded by analysts at D Boral Capital to a "strong-buy" rating.

Turn Therapeutics (NASDAQ:TTRX) was upgraded by analysts at D Boral Capital to a "strong-buy" rating.

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}